Exicure Inc (XCUR)
Who owns Exicure Inc (XCUR)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.7% of the shares are freely tradable; institutional investors hold 2.7%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| The Carlyle Group Inc | 0.88 | 56,328 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 0.66 | 42,044 | +0.0 | 12/31/2025 |
| Geode Capital Management, LLC | 0.58 | 36,913 | +24.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 0.52 | 32,983 | +0.0 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.21 | 13,161 | +0.0 | 03/31/2026 |
| Northern Trust Corp | 0.17 | 10,686 | +0.0 | 03/31/2026 |
| BlackRock Inc | 0.15 | 9,353 | +124.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Institutional Extnd Mkt Idx Tr | 0.45 | 28,883 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.33 | 20,877 | -0.4 | 04/30/2026 |
| iShares Micro-Cap ETF | 0.14 | 9,034 | +0.0 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 8. Jul 2026 | Exicure HiTron Inc. | 10% Owner | Other | 117,441 | 4.50 | 528,485 |
| 26. Jun 2026 | Exicure HiTron Inc. | 10% Owner | Other | 253,195 | 4.50 | 1,139,378 |
| 24. Jun 2026 | Exicure HiTron Inc. | 10% Owner | Other | 123,456 | 4.50 | 555,552 |
| 23. Jun 2026 | Exicure HiTron Inc. | 10% Owner | Other | 129,183 | 4.50 | 581,324 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.